Skip to main content
Exclusive Savings: Take 10% OFF All Cenmed Products | Upgrade Your Lab For Less Shop Now
US English

Aladdin Scientific

VTP50469 fumarate (C007B-432549)

VTP50469 fumarate is a potent, highly selective and orally active Menin-MLL interaction inhibitor with a K i of 104 pM. VTP50469 fumarate has potently anti-leukemia activityIn VitroVTP50469 more potently and rapidly inhibits cell proliferation in a

Description
VTP50469 fumarate is a potent, highly selective and orally active Menin-MLL interaction inhibitor with a K i of 104 pM. VTP50469 fumarate has potently anti-leukemia activityIn VitroVTP50469 more potently and rapidly inhibits cell proliferation in a concentration-dependent manner in MLL-r cell lines carrying (MOLM13 (IC 50 of 13 nM), THP1 (IC 50 of 37 nM), NOMO1 (IC 50 of 30 nM), ML2 (IC 50 of 16 nM), EOL1 (IC 50 of 20 nM), and murine MLL-AF9 cells (IC 50 of 15 nM)) and ALL (KOPN8 (IC 50 of 15 nM), HB11;19 (IC 50 of 36 nM), MV4;11 (IC 50 of 17 nM), SEMK2 (IC 50 of 27 nM), and RS4;11 (IC 50 of 25 nM)) cell lines. At early timepoints MLL-r B cell ALL (B-ALL) cell lines, but not MLL-r AML cell lines, underwent apoptosis in response to VTP50469 in a dose-dependent manner. MLL-r AML cell lines underwent dose-dependent differentiation starting at 4-6 days of exposure to VTP50469. VTP50469 displaces Menin from protein complexes and inhibits chromatin occupancy of MLL at select genes. Loss of MLL binding led to changes in gene expression, differentiation, and apoptosis. MCE has not independently confirmed the accuracy of these methods. They are for reference only.In VivoVTP50469 (15-60 mg/kg; oral administration; twice a day; for 28 days; NSG mice) treatment is highly efficacious across all dosage levels and all treatment groups have a significant survival advantage. Mice dosed at 30 and 60 mg/kg VTP50469 extends survival advantage . MCE has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: Unconditioned immunodeficient (NSG) mice with MV4;11 cells Dosage: 15 mg/kg, 30 mg/kg, and 60 mg/kg Administration: Oral administration; twice a day; for 28 days Result: Was highly efficacious across all dosage levels and all treatment groups had a significant survival advantage over the control group.Form:SolidIC50& Target:Ki: 104 pM (Menin-MLL interaction). Specification: 0.99 Molecular Formula: C32H47FN6O4S.3/2C4H4O4 Molecular Weight: 804.93
Specifications
UPC:
51111856
Condition:
New
Weight:
1.06 Ounces
HazmatClass:
No
Quantity:
1
Unit of Measurement:
EA
WeightUOM:
LB
MPN:
V646888-10mg
CAS:
2169919-29-1
Product Size:
10mg
Catalog No. C007B-432549
Price: $1,411.91
List Price: $1,568.78
  • Fast shipping — 3-day lead time
  • Guaranteed quality & reliable delivery
  • Shipping Lead-Time: 8-12 weeks
Adding to cart… The item has been added
Request a Quote

Enjoy exclusive benefits, including discounted pricing on bulk orders, by opening a Cenmed Business Account. Learn More.